deepblue4you
- NeoGenomics (NASDAQ:NEO) shares climbed ~20% in the premarket on Friday after the company announced a major victory in a legal battle over a patent dispute with its rival cancer test developer Natera (NASDAQ:NTRA).
- In a statement on Friday, the company stated
